Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Philip Rosenfeld
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Physiology
Procedures
Chemicals & Drugs
Anatomy
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
14
Puliafito, Carmen
13
Bressler, Neil
13
Flynn, Harry
9
Reaves, Al
8
Slakter, Jason
8
Bressler, Susan
8
Michels, Stephan
8
Potter, Michael
7
Dubovy, Sander
7
Gregori, Giovanni
7
Schmidt-Erfurth, Ursula
6
Smiddy, William
6
Strong, Andrew
6
Davis, Janet
6
Aaberg, Thomas
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Philip Rosenfeld (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Querques Giuseppe; Noci Nicola Delle; Aaberg Thomas; Rosenfeld Philip J
Diagnostic and therapeutic challenges.
Retina (Philadelphia, Pa.) 2009;29(8):1195-200.
-
2009: Stepien Kimberly E; Rosenfeld Philip J; Puliafito Carmen A; Feuer William; Shi Wei; Al-Attar Luma; Dubovy Sander R; Murray Timothy G; Davis Janet L; Lee Wen-Hsiang; Schwartz Stephen G; Smiddy William E; Berrocal Audina M; Flynn Harry W
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) 2009;29(8):1067-73.
-
2009: Leng Theodore; Rosenfeld Philip J; Gregori Giovanni; Puliafito Carmen A; Punjabi Omar S
Spectral domain optical coherence tomography characteristics of cuticular drusen.
Retina (Philadelphia, Pa.) 2009;29(7):988-93.
-
2009: Gregori Ninel Z; Rattan Ginger Henson; Rosenfeld Philip J; Puliafito Carmen A; Feuer William; Flynn Harry W; Berrocal Audina M; Al-Attar Luma; Dubovy Sander; Smiddy William E; Schwartz Stephen G; Lee Wen-Hsiang; Murray Timothy G
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.
Retina (Philadelphia, Pa.) 2009;29(7):913-25.
-
2009: Lalwani Geeta A; Rosenfeld Philip J; Fung Anne E; Dubovy Sander R; Michels Stephen; Feuer William; Davis Janet L; Flynn Harry W; Esquiabro Maria
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
American journal of ophthalmology 2009;148(1):43-58.e1.
-
2009: Ciulla Thomas A; Rosenfeld Philip J
Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Current opinion in ophthalmology 2009;20(3):158-65.
-
2009: Ciulla Thomas A; Rosenfeld Philip J
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Current opinion in ophthalmology 2009;20(3):166-74.
-
2009: Rosenfeld Philip J; Goodman Kenneth W
When is off-label drug use in the patient's best interest?
American journal of ophthalmology 2009;147(5):761-3.
-
2009: Moraczewski A L; Lee R K; Palmberg P F; Rosenfeld P J; Feuer W J
Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
The British journal of ophthalmology 2009;93(5):589-93.
-
2009: Lujan Brandon J; Rosenfeld Philip J; Gregori Giovanni; Wang Fenghua; Knighton Robert W; Feuer William J; Puliafito Carmen A
Spectral domain optical coherence tomographic imaging of geographic atrophy.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2009;40(2):96-101.
-
2009: Gregori N Z; Berrocal A M; Gregori G; Murray T G; Knighton R W; Flynn H W; Dubovy S; Puliafito C A; Rosenfeld P J
Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis.
The British journal of ophthalmology 2009;93(3):373-8.
-
2009: Kovach Jaclyn L; Rosenfeld Philip J
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
Retina (Philadelphia, Pa.) 2009;29(1):27-32.
-
2009: Komarowska Izabela; Heilweil Gad; Rosenfeld Philip J; Perlman Ido; Loewenstein Anat
Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
Retina (Philadelphia, Pa.) 2009;29(1):98-105.
-
2008: Geitzenauer Wolfgang; Michels Stephan; Prager Franz; Rosenfeld Philip J; Kornek Gabriela; Vormittag Laurenz; Schmidt-Erfurth Ursula
Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study.
Retina (Philadelphia, Pa.) 2008;28(10):1375-86.
-
2008: Gregori Ninel Z; Gaitan Jaime; Rosenfeld Philip J; Puliafito Carmen A; Feuer William; Flynn Harry W; Berrocal Audina M; Al-Attar Luma; Dubovy Sander; Smiddy William E; Schwartz Stephen G; Lee Wen-Hsiang; Murray Timothy G
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2008;28(9):1325-37.
-
2008: Punjabi Omar S; Rich Ryan; Davis Janet L; Gregori Giovanni; Flynn Harry W; Lujan Brandon J; Rosenfeld Philip J; Puliafito Carmen A
Imaging serpiginous choroidopathy with spectral domain optical coherence tomography.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008;39(4 Suppl):S95-8.
-
2008: Lujan Brandon J; Wang Fenghua; Gregori Giovanni; Rosenfeld Philip J; Knighton Robert W; Puliafito Carmen A; Danis Ronald P; Hubbard Larry D; Chang Robert T; Budenz Donald L; Seider Michael I; Knight O'Rese
Calibration of fundus images using spectral domain optical coherence tomography.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008;39(4 Suppl):S15-20.
-
2008: Stewart M W; Rosenfeld P J
Predicted biological activity of intravitreal VEGF Trap.
The British journal of ophthalmology 2008;92(5):667-8.
-
2008: Sun Xiao-Dong; Xu Wei-Qi; Rosenfeld Philip J
[Therapeutic efficacy and safety of off-label use of Bevacizumab for the treatment of neovascular diseases of the eye]
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2008;44(3):281-4.
-
2008: Tsechpenakis Gabriel; Lujan Brandon; Martinez Oscar; Gregori Giovanni; Rosenfeld Philip J
Geometric deformable model driven by CoCRFs: application to optical coherence tomography.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2008;11(Pt 1):883-91.
-
2007: Rosenfeld Philip J; Boyer David S; Bressler Neil M; Fish Gary; Grizzard W Sanderson; Hao Yong; Hnik Peter; Hudson Henry L; Singerman Lawrence; Slakter Jason S;
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.
American journal of ophthalmology 2007;144(6):970-972.
-
2007: Rosenfeld Philip J
New treatments for age-related macular degeneration.
Lancet 2007;370(9597):1479; author reply 1480.
-
2007: Charles Steve; Rosenfeld Philip J; Gayer Steven
Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.
Retina (Philadelphia, Pa.) 2007;27(7):813-5.
-
2007: Fung Anne E; Lalwani Geeta A; Rosenfeld Philip J; Dubovy Sander R; Michels Stephan; Feuer William J; Puliafito Carmen A; Davis Janet L; Flynn Harry W; Esquiabro Maria
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
American journal of ophthalmology 2007;143(4):566-83.
-
2007: Rosenfeld P J
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.
The British journal of ophthalmology 2007;91(2):128-30.
-
2007: Lin Richard C; Rosenfeld Philip J
Antiangiogenic therapy in neovascular age-related macular degeneration.
International ophthalmology clinics 2007;47(1):117-37.
-
2006: Saperstein David A; Rosenfeld Philip J; Bressler Neil M; Rosa Robert H; Sternberg Paul; Aaberg Thomas M; Aaberg Thomas M; Weisberger Annemarie
Verteporfin therapy for CNV secondary to OHS.
Ophthalmology 2006;113(12):2371.e1-3.
-
2006: Moshfeghi Andrew A; Rosenfeld Philip J; Puliafito Carmen A; Michels Stephan; Marcus Erin N; Lenchus Joshua D; Venkatraman Anna S
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.
Ophthalmology 2006;113(11):2002.e1-12.
-
2006: Fung A E; Rosenfeld P J; Reichel E
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.
The British journal of ophthalmology 2006;90(11):1344-9.
-
2006: Geitzenauer W; Michels S; Prager F; Kornek G; Vormittag L; Rosenfeld P; Schmidt-Erfurth U
[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration]
Klinische Monatsblätter für Augenheilkunde 2006;223(10):822-7.
-
2006: Gregori Ninel Z; Rosenfeld Philip J; Puliafito Carmen A; Flynn Harry W; Lee Ji Eun; Mavrofrides Elias C; Smiddy William E; Murray Timothy G; Berrocal Audina M; Scott Ingrid U; Gregori Giovanni
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2006;26(8):889-95.
-
2006: Rosenfeld Philip J; Brown David M; Heier Jeffrey S; Boyer David S; Kaiser Peter K; Chung Carol Y; Kim Robert Y;
Ranibizumab for neovascular age-related macular degeneration.
The New England journal of medicine 2006;355(14):1419-31.
-
2006: Rosenfeld Philip J; Rich Ryan M; Lalwani Geeta A
Ranibizumab: Phase III clinical trial results.
Ophthalmology clinics of North America 2006;19(3):361-72.
-
2006: Rosenfeld Philip J
Intravitreal avastin: the low cost alternative to lucentis?
American journal of ophthalmology 2006;142(1):141-3.
-
2006: Michels Stephan; Schmidt-Erfurth Ursula; Rosenfeld Philip J
Promising new treatments for neovascular age-related macular degeneration.
Expert opinion on investigational drugs 2006;15(7):779-93.
-
2006: Rich Ryan M; Rosenfeld Philip J; Puliafito Carmen A; Dubovy Sander R; Davis Janet L; Flynn Harry W; Gonzalez Serafin; Feuer William J; Lin Richard C; Lalwani Geeta A; Nguyen Jackie K; Kumar Gaurav
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) 2006;26(5):495-511.
-
2006: Wirthlin Robert; Song Alice; Song Julia; Rosenfeld Philip J
Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.
Archives of ophthalmology 2006;124(5):741-3.
-
2006: Rosenfeld Philip J; Heier Jeffrey S; Hantsbarger Gary; Shams Naveed
Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Ophthalmology 2006;113(4):623.e1.
-
2006: Heier Jeffrey S; Antoszyk Andrew N; Pavan Peter Reed; Leff Steven R; Rosenfeld Philip J; Ciulla Thomas A; Dreyer Richard F; Gentile Ronald C; Sy Judy P; Hantsbarger Gary; Shams Naveed
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Ophthalmology 2006;113(4):633.e1-4.
-
2005: Singerman Lawrence J; Brucker Alexander J; Jampol Lee M; Lim Jennifer I; Rosenfeld Philip; Schachat Andrew P; Spaide Richard F
Neovascular age-related macular degeneration: roundtable.
Retina (Philadelphia, Pa.) 2005;25(7 Suppl):S1-S22.
-
2005: Bressler Neil M; Bressler Susan B; Haynes Laurie A; Hao Yong; Kaiser Peter K; Miller Joan W; Naor Joel; Potter Michael J; Pournaras Constantin J; Reaves Al; Rosenfeld Philip J; Schmidt-Erfurth Ursula; Slakter Jason S; Strong Andrew; Vannier Stéphane
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Archives of ophthalmology 2005;123(9):1283-5.
-
2005: Rosenfeld Philip J; Fung Anne E; Puliafito Carmen A
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2005;36(4):336-9.
-
2005: Rosenfeld Philip J; Moshfeghi Andrew A; Puliafito Carmen A
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2005;36(4):331-5.
-
2005: Michels S; Rosenfeld P J
[Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis]
Klinische Monatsblätter für Augenheilkunde 2005;222(6):480-4.
-
2005: Michels Stephan; Rosenfeld Philip J; Puliafito Carmen A; Marcus Erin N; Venkatraman Anna S
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.
Ophthalmology 2005;112(6):1035-47.
-
2005: Rosenfeld Philip J; Schwartz Steven D; Blumenkranz Mark S; Miller Joan W; Haller Julia A; Reimann James D; Greene William L; Shams Naveed
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
Ophthalmology 2005;112(6):1048-53.
-
2005: Azab Mohammad; Boyer David S; Bressler Neil M; Bressler Susan B; Cihelkova Ilona; Hao Young; Immonen Ilkka; Lim Jennifer I; Menchini Ugo; Naor Joel; Potter Michael J; Reaves Al; Rosenfeld Philip J; Slakter Jason S; Soucek Peter; Strong H Andrew; Wenkstern Andrea; Su Xiang Yao; Yang Yit C;
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Archives of ophthalmology 2005;123(4):448-57.
-
2004: Bandello Francesco; Blinder Kevin; Bressler Neil M; Brown Alison L; Miller Joan W; Potter Michael J; Pournaras Constantin; Reaves Al; Rosenfeld Philip J; Slakter Jason S; Soubrane Gisele; Strong H Andrew; Stur Michael;
Verteporfin in Photodynamic Therapy: report no. 5.
Ophthalmology 2004;111(11):2144.
-
2004: Hunter Megan A; Dunbar Mark T; Rosenfeld Phillip J
Retinal angiomatous proliferation: clinical characteristics and treatment options.
Optometry (St. Louis, Mo.) 2004;75(9):577-88.
-
2004: Rosenfeld Philip J; Saperstein David A; Bressler Neil M; Reaves Troy A; Sickenberg Michel; Rosa Robert H; Sternberg Paul; Aaberg Thomas M; Aaberg Thomas M;
Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Ophthalmology 2004;111(9):1725-33.
-
2004: Weeks Daniel E; Conley Yvette P; Tsai Hui-Ju; Mah Tammy S; Schmidt Silke; Postel Eric A; Agarwal Anita; Haines Jonathan L; Pericak-Vance Margaret A; Rosenfeld Philip J; Paul T Otis; Eller Andrew W; Morse Lawrence S; Dailey J P; Ferrell Robert E; Gorin Michael B
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.
American journal of human genetics 2004;75(2):174-89.
-
2004: Arnold Jennifer J; Blinder Kevin J; Bressler Neil M; Bressler Susan B; Burdan Amy; Haynes Laurie; Lim Jennifer I; Miller Joan W; Potter Michael J; Reaves Al; Rosenfeld Philip J; Sickenberg Michel; Slakter Jason S; Soubrane Gisèle; Strong H Andrew; Stur Michael;
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
American journal of ophthalmology 2004;137(4):683-96.
-
2004: Azab Mohammad; Benchaboune Mustapha; Blinder Kevin J; Bressler Neil M; Bressler Susan B; Gragoudas Evangelos S; Fish Gary Edd; Hao Yong; Haynes Laurie; Lim Jennifer I; Menchini Ugo; Miller Joan W; Mones Jordi; Potter Michael J; Reaves Al; Rosenfeld Philip J; Strong Andrew; Su Xiang Yao; Slakter Jason S; Schmidt-Erfurth Ursula; Sorenson John A;
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Retina (Philadelphia, Pa.) 2004;24(1):1-12.
-
2003: Scott Ingrid U; Flynn Harry W; Rosenfeld Philip J
Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema.
American journal of ophthalmology 2003;136(4):737-9.
-
2003: Blinder Keven J; Bradley Shannon; Bressler Neil M; Bressler Susan B; Donati Guy; Hao Yong; Ma Colin; Menchini Ugo; Miller Joan; Potter Michael J; Pournaras Constantin; Reaves Al; Rosenfeld Philip J; Strong H Andrew; Stur Michael; Su Xiang Yao; Virgili Gianni;
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
American journal of ophthalmology 2003;136(3):407-18.
-
2003: Barbazetto Irene; Burdan Amy; Bressler Neil M; Bressler Susan B; Haynes Laurie; Kapetanios Anastasios D; Lukas Julius; Olsen Karl; Potter Michael; Reaves Al; Rosenfeld Philip; Schachat Andrew P; Strong H Andrew; Wenkstern Andrea;
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
Archives of ophthalmology 2003;121(9):1253-68.
-
2003: Blinder Kevin J; Blumenkranz Mark S; Bressler Neil M; Bressler Susan B; Donato Guy; Lewis Hilel; Lim Jennifer I; Menchini Ugo; Miller Joan W; Mones Jordi M; Potter Michael J; Pournaras Constantin; Reaves Al; Rosenfeld Philip; Schachat Andrew P; Schmidt-Erfurth Ursula; Sickenberg Michel; Singerman Lawrence J; Slakter Jason S; Strong H Andrew; Virgili Gianni; Williams George A
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Ophthalmology 2003;110(4):667-73.
-
2002: Blumenkranz Mark S; Bressler Neil M; Bressler Susan B; Donati Guy; Fish Gary Edd; Haynes Laurie A; Lewis Hilel; Miller Joan W; Monés Jordi M; Potter Michael J; Pournaras Constantin; Reaves Al; Rosenfeld Philip J; Schachat Andrew P; Schmidt-Erfurth Ursula; Sickenburg Michel; Singerman Lawrence J; Slakter Jason S; Strong Andrew; Vannier Stéphane;
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Archives of ophthalmology 2002;120(10):1307-14.
-
2002: Saperstein David A; Rosenfeld Philip J; Bressler Neil M; Rosa Robert H; Sickenberg Michel; Sternberg Paul; Aaberg Thomas M; Aaberg Thomas M; Reaves Troy A;
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Ophthalmology 2002;109(8):1499-505.
-
2002: Loo Roy H; Scott Ingrid U; Flynn Harry W; Gass J Donald M; Murray Timothy G; Lewis Mary Lou; Rosenfeld Phillip J; Smiddy William E
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.
Retina (Philadelphia, Pa.) 2002;22(1):19-24.
-
2001: Weeks D E; Conley Y P; Tsai H J; Mah T S; Rosenfeld P J; Paul T O; Eller A W; Morse L S; Dailey J P; Ferrell R E; Gorin M B
Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions.
American journal of ophthalmology 2001;132(5):682-92.
-
2001: Briggs C E; Rucinski D; Rosenfeld P J; Hirose T; Berson E L; Dryja T P
Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration.
Investigative ophthalmology & visual science 2001;42(10):2229-36.
-
2001: Yen M T; Rosenfeld P J
Persistent indocyanine green angiographic findings in multiple evanescent white dot syndrome.
Ophthalmic surgery and lasers 2001;32(2):156-8.
-
1999: Tabandeh H; Rosenfeld P J; Alexandrakis G; Kronish J P; Chaudhry N A
Purtscher-like retinopathy associated with pancreatic adenocarcinoma.
American journal of ophthalmology 1999;128(5):650-2.
-
1999: Tabandeh H; Flynn H W; Scott I U; Lewis M L; Rosenfeld P J; Rodriguez F; Rodriguez A; Singerman L J; Schiffman J
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization.
Ophthalmology 1999;106(11):2063-7.
-
1999: Caldwell G M; Kakuk L E; Griesinger I B; Simpson S A; Nowak N J; Small K W; Maumenee I H; Rosenfeld P J; Sieving P A; Shows T B; Ayyagari R
Bestrophin gene mutations in patients with Best vitelliform macular dystrophy.
Genomics 1999;58(1):98-101.
-
1998: Chaudhry N A; Tabandeh H; Rosenfeld P J; Miller D; Davis J
Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Archives of ophthalmology 1998;116(9):1251.
-
1998: Rosenfeld P J; Flynn H W; McDonald H R; Rubsamen P E; Smiddy W E; Sipperley J O; Boniuk I; Packer A J
Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis.
Ophthalmic surgery and lasers 1998;29(3):190-7.
-
1995: Rosenfeld P J; Hahn L B; Sandberg M A; Dryja T P; Berson E L
Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
Investigative ophthalmology & visual science 1995;36(11):2186-92.
-
1994: Rosenfeld P J; McKusick V A; Amberger J S; Dryja T P
Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous.
Journal of medical genetics 1994;31(12):903-15.
-
1992: Rosenfeld P J; Cowley G S; McGee T L; Sandberg M A; Berson E L; Dryja T P
A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
Nature genetics 1992;1(3):209-13.
-
1987: Kelly T J; Rosenfeld P J; Wides R J; O'Neill E A; Li J J; Wold M S
Replication of adenovirus and SV40 chromosomes in vitro.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1987;317(1187):429-38.
-
1987: Jeang K T; Rawlins D R; Rosenfeld P J; Shero J H; Kelly T J; Hayward G S
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.
Journal of virology 1987;61(5):1559-70.
-
1987: Rosenfeld P J; O'Neill E A; Wides R J; Kelly T J
Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication.
Molecular and cellular biology 1987;7(2):875-86.
-
1987: Jones K A; Kadonaga J T; Rosenfeld P J; Kelly T J; Tjian R
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.
Cell 1987;48(1):79-89.
-
1986: Rosenfeld P J; Kelly T J
Purification of nuclear factor I by DNA recognition site affinity chromatography.
The Journal of biological chemistry 1986;261(3):1398-408.
-
1984: Rawlins D R; Rosenfeld P J; Wides R J; Challberg M D; Kelly T J
Structure and function of the adenovirus origin of replication.
Cell 1984;37(1):309-19.
-
1981: Angus C W; Lane M D; Rosenfeld P J; Kelly T J
Increase in translatable mRNA for mitochondrial pyruvate carboxylase during differentiation of 3T3 preadipocytes.
Biochemical and biophysical research communications 1981;103(4):1216-22.
-
1973: Bhagavan H N; Coleman M; Coursin D B; Rosenfeld P
Pyridoxal-5-phosphate levels in whole blood in home-reared patients with trisomy 21.
Lancet 1973;1(7808):889-90.
Sign-in to see more
